(Q81244853)
Statements
Short-term efficacy and long-term compliance/treatment failure of the alpha1 blocker naftopidil for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (English)
Naoya Masumori
Taiji Tsukamoto
Jiro Hashimoto
Naoki Itoh
The Sapporo Medical University Naftopidil Study Group